Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pilgrim

Showing results (291-300 of 430) with videos related to

Pageof 43
Sort By:
American Heart Journal|June 7, 2011
Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routesPeter Wenaweser, Thomas Pilgrim, Nadja Roth, et al.
Journal of the American Heart Association|March 17, 2016
Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE TrialRainer Zbinden, Raffaele Piccolo, Dik Heg, et al.
JACC. Cardiovascular Imaging|March 19, 2026
Association of Bicuspid Aortic Valve Morphology With Outcomes Among Patients Undergoing Transcatheter Aortic Valve ReplacementDaryoush Samim, Daijiro Tomii, Jonas Lanz, et al.
Circulation. Cardiovascular Interventions|February 7, 2015
Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantationCrochan J O'Sullivan, Stefan Stortecky, Anne Bütikofer, et al.
Frontiers in Cardiovascular Medicine|August 1, 2022
Diagnostic performance of cardiac magnetic resonance segmental myocardial strain for detecting microvascular obstruction and late gadolinium enhancement in patients presenting after a ST-elevation myocardial infarctionChristoph Gräni, Anselm W Stark, Kady Fischer, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization a randomized controlled trialThomas Pilgrim, Lorenz Räber, Andreas Limacher, et al.
Circulation. Cardiovascular Interventions|March 30, 2012
The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stentsThomas Pilgrim, Florian Vetterli, Bindu Kalesan, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary RevascularizationKyohei Yamaji, Thomas Zanchin, Christian Zanchin, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 5, 2015
Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillationSteffen Gloekler, Samera Shakir, Janosch Doblies, et al.
Circulation. Cardiovascular Interventions|November 12, 2017
Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry ModelThomas Pilgrim, Anna Franzone, Stefan Stortecky, et al.
Pageof 43

Showing results (291-300 of 430) with videos related to

Sort By:
Pageof 43
American Heart Journal|June 7, 2011
Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routesPeter Wenaweser, Thomas Pilgrim, Nadja Roth, et al.
Journal of the American Heart Association|March 17, 2016
Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE TrialRainer Zbinden, Raffaele Piccolo, Dik Heg, et al.
JACC. Cardiovascular Imaging|March 19, 2026
Association of Bicuspid Aortic Valve Morphology With Outcomes Among Patients Undergoing Transcatheter Aortic Valve ReplacementDaryoush Samim, Daijiro Tomii, Jonas Lanz, et al.
Circulation. Cardiovascular Interventions|February 7, 2015
Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantationCrochan J O'Sullivan, Stefan Stortecky, Anne Bütikofer, et al.
Frontiers in Cardiovascular Medicine|August 1, 2022
Diagnostic performance of cardiac magnetic resonance segmental myocardial strain for detecting microvascular obstruction and late gadolinium enhancement in patients presenting after a ST-elevation myocardial infarctionChristoph Gräni, Anselm W Stark, Kady Fischer, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization a randomized controlled trialThomas Pilgrim, Lorenz Räber, Andreas Limacher, et al.
Circulation. Cardiovascular Interventions|March 30, 2012
The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stentsThomas Pilgrim, Florian Vetterli, Bindu Kalesan, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary RevascularizationKyohei Yamaji, Thomas Zanchin, Christian Zanchin, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 5, 2015
Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillationSteffen Gloekler, Samera Shakir, Janosch Doblies, et al.
Circulation. Cardiovascular Interventions|November 12, 2017
Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry ModelThomas Pilgrim, Anna Franzone, Stefan Stortecky, et al.
Pageof 43